These data suggest that the homing and trafficking of tumor-infiltrating Treg-cells to the tumor mass is dependent on the chemokine receptor CCR6 in vivo in the CRC mouse model grafted with CMT93. This evidence concerns the gene CCR6 and colorectal carcinoma.